Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study

Garris, Cindy; Czarnogorski, Maggie; Dalessandro, Marybeth; D’Amico, Ronald; Nwafor, Toyin; Williams, Will; Merrill, Deanna; Wang, Yuanyuan; Stassek, Larissa; Wohlfeiler, Michael; Sinclair, Gary; Mena, Leandro; Thedinger, Blair; Flamm, Jason; Benson, Paul; Spreen, William

doi:10.1002/jia2.26006

Public

Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study

Published in Journal of the International AIDS Society • Sep 1, 2022

Authors:

Cindy Garris

Maggie Czarnogorski

Marybeth Dalessandro

Abstract

INTRODUCTION: The CUSTOMIZE hybrid III implementation-effectiveness study evaluated implementation of once-monthly long-acting (LA) cabotegravir + rilpivirine in diverse US healthcare settings. Here, we report patient participant perspectives after 12 months in CUSTOMIZE. METHODS: CUSTOMIZE was a ph...

Subject

Rilpivirine

Medicine

Regimen

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!